Tradestie Institutional Equity Comparison Engine
NGNE vs OKUR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NGNE Overall Edge
NGNE Captures Institutional Edge (3โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neurogene, Inc. Common Stock (NGNE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NGNE trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OKUR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NGNE sits in BREAKDOWN (2nd %ile IV; Dealer Gamma Walls on Pro) against OKUR sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NGNE N/M vs OKUR N/M Fwd P/E
Growth & Margin Winner
NGNE
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
NGNE
1Y +5.5% vs -2.2% ยท 52W Pos 22% vs 20%
Options & Structure Winner
NGNE
BREAKDOWN (2nd %ile IV) vs SURGE (100th %ile IV)
NGNE
NASDAQ
Neurogene, Inc. Common Stock
Pharmaceutical Preparations
$22.15
-3.4% 1D
Market Cap
$474.7M
1M Return
-8.77%
1Y Return
+5.53%
Forward P/E
N/M
Unified AI Score
42.0 / 100
HOLD
Tech 32.0
Fund 51.0
Flow 68.0
Mom 60.0
OKUR
NASDAQ
OnKure Therapeutics, Inc. Class A Common Stock
Pharmaceutical Preparations
$2.70
-2.17% 1D
Market Cap
$113.7M
1M Return
+4.65%
1Y Return
-2.17%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 20.0
Fund 46.0
Flow 64.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NGNE +5.53%
OKUR -2.17%
Spread: +7.7 pp (NGNE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NGNE TTM Op. Margin: 0.0%
OKUR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NGNE vs OKUR. Trailing 12-month operating profitability (NGNE 0.0% vs OKUR 0.0%) and valuation multiples (NGNE N/M vs OKUR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NGNE | OKUR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $474.7M | $113.7M | Larger Scale | NGNE |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -38.4% | -55.2% | Higher ROE | NGNE |
| 52-Week Range Position Momentum | 22% ($16โ$44) | 20% ($2โ$5) | Stronger Trend | NGNE |
| Beta / 30D Volatility Risk Regime | 1.46ฮฒ ยท 82% Vol | 0.96ฮฒ ยท 100% Vol | Lower Realized Risk | NGNE |
| Unified Institutional Score Composite Signal | 42.0 / 100 (HOLD) | 36.0 / 100 (SELL) | Higher Composite | NGNE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NGNE vs OKUR Buy Guide
NGNE
BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
OKUR
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NGNE nor OKUR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.